308 related articles for article (PubMed ID: 23316962)
1. Matrix metalloproteinases: drug targets for myocardial infarction.
Yabluchanskiy A; Li Y; Chilton RJ; Lindsey ML
Curr Drug Targets; 2013 Mar; 14(3):276-86. PubMed ID: 23316962
[TBL] [Abstract][Full Text] [Related]
2. Delivery of a matrix metalloproteinase-responsive hydrogel releasing TIMP-3 after myocardial infarction: effects on left ventricular remodeling.
Purcell BP; Barlow SC; Perreault PE; Freeburg L; Doviak H; Jacobs J; Hoenes A; Zellars KN; Khakoo AY; Lee T; Burdick JA; Spinale FG
Am J Physiol Heart Circ Physiol; 2018 Oct; 315(4):H814-H825. PubMed ID: 29979624
[TBL] [Abstract][Full Text] [Related]
3. Early matrix metalloproteinase-12 inhibition worsens post-myocardial infarction cardiac dysfunction by delaying inflammation resolution.
Iyer RP; Patterson NL; Zouein FA; Ma Y; Dive V; de Castro Brás LE; Lindsey ML
Int J Cardiol; 2015 Apr; 185():198-208. PubMed ID: 25797678
[TBL] [Abstract][Full Text] [Related]
4. Possible mechanism by which renal sympathetic denervation improves left ventricular remodelling after myocardial infarction.
Zheng XX; Li XY; Lyu YN; He YY; Wan WG; Zhu HL; Jiang XJ
Exp Physiol; 2016 Feb; 101(2):260-71. PubMed ID: 26556551
[TBL] [Abstract][Full Text] [Related]
5. MMP induction and inhibition in myocardial infarction.
Lindsey ML
Heart Fail Rev; 2004 Jan; 9(1):7-19. PubMed ID: 14739764
[TBL] [Abstract][Full Text] [Related]
6. Theranostic Contribution of Extracellular Matrix Metalloprotease Inducer-Paramagnetic Nanoparticles Against Acute Myocardial Infarction in a Pig Model of Coronary Ischemia-Reperfusion.
Ramirez-Carracedo R; Sanmartin M; Ten A; Hernandez I; Tesoro L; Diez-Mata J; Botana L; Ovejero-Paredes K; Filice M; Alberich-Bayarri A; Martí-Bonmatí L; Largo-Aramburu C; Saura M; Zamorano JL; Zaragoza C
Circ Cardiovasc Imaging; 2022 Jun; 15(6):e013379. PubMed ID: 35678191
[TBL] [Abstract][Full Text] [Related]
7. Gender differences in cardiac function during early remodeling after acute myocardial infarction in mice.
Cavasin MA; Tao Z; Menon S; Yang XP
Life Sci; 2004 Sep; 75(18):2181-92. PubMed ID: 15325844
[TBL] [Abstract][Full Text] [Related]
8. Sphingosine-1-Phosphate Receptor Agonist Fingolimod Increases Myocardial Salvage and Decreases Adverse Postinfarction Left Ventricular Remodeling in a Porcine Model of Ischemia/Reperfusion.
Santos-Gallego CG; Vahl TP; Goliasch G; Picatoste B; Arias T; Ishikawa K; Njerve IU; Sanz J; Narula J; Sengupta PP; Hajjar RJ; Fuster V; Badimon JJ
Circulation; 2016 Mar; 133(10):954-66. PubMed ID: 26826180
[TBL] [Abstract][Full Text] [Related]
9. Selective matrix metalloproteinase inhibition reduces left ventricular remodeling but does not inhibit angiogenesis after myocardial infarction.
Lindsey ML; Gannon J; Aikawa M; Schoen FJ; Rabkin E; Lopresti-Morrow L; Crawford J; Black S; Libby P; Mitchell PG; Lee RT
Circulation; 2002 Feb; 105(6):753-8. PubMed ID: 11839633
[TBL] [Abstract][Full Text] [Related]
10. Matrix Metalloproteinases in Myocardial Infarction and Heart Failure.
DeLeon-Pennell KY; Meschiari CA; Jung M; Lindsey ML
Prog Mol Biol Transl Sci; 2017; 147():75-100. PubMed ID: 28413032
[TBL] [Abstract][Full Text] [Related]
11. Targeting MMP-2 to treat ischemic heart injury.
Hughes BG; Schulz R
Basic Res Cardiol; 2014 Jul; 109(4):424. PubMed ID: 24986221
[TBL] [Abstract][Full Text] [Related]
12. Post-infarct morphine treatment mitigates left ventricular remodeling and dysfunction in a rat model of ischemia-reperfusion.
Rajani SF; Imani A; Faghihi M; Izad M; Kardar GA; Salehi Z
Eur J Pharmacol; 2019 Mar; 847():61-71. PubMed ID: 30684466
[TBL] [Abstract][Full Text] [Related]
13. Myocardial overexpression of TIMP3 after myocardial infarction exerts beneficial effects by promoting angiogenesis and suppressing early proteolysis.
Takawale A; Zhang P; Azad A; Wang W; Wang X; Murray AG; Kassiri Z
Am J Physiol Heart Circ Physiol; 2017 Aug; 313(2):H224-H236. PubMed ID: 28550172
[TBL] [Abstract][Full Text] [Related]
14. Targeted deletion or pharmacological inhibition of MMP-2 prevents cardiac rupture after myocardial infarction in mice.
Matsumura S; Iwanaga S; Mochizuki S; Okamoto H; Ogawa S; Okada Y
J Clin Invest; 2005 Mar; 115(3):599-609. PubMed ID: 15711638
[TBL] [Abstract][Full Text] [Related]
15. Early activation of matrix metalloproteinases underlies the exacerbated systolic and diastolic dysfunction in mice lacking TIMP3 following myocardial infarction.
Kandalam V; Basu R; Abraham T; Wang X; Awad A; Wang W; Lopaschuk GD; Maeda N; Oudit GY; Kassiri Z
Am J Physiol Heart Circ Physiol; 2010 Oct; 299(4):H1012-23. PubMed ID: 20675565
[TBL] [Abstract][Full Text] [Related]
16. Matrix metalloproteinase inhibition after myocardial infarction: a new approach to prevent heart failure?
Creemers EE; Cleutjens JP; Smits JF; Daemen MJ
Circ Res; 2001 Aug; 89(3):201-10. PubMed ID: 11485970
[TBL] [Abstract][Full Text] [Related]
17. Intracoronary delivery of recombinant TIMP-3 after myocardial infarction: effects on myocardial remodeling and function.
Barlow SC; Doviak H; Jacobs J; Freeburg LA; Perreault PE; Zellars KN; Moreau K; Villacreses CF; Smith S; Khakoo AY; Lee T; Spinale FG
Am J Physiol Heart Circ Physiol; 2017 Oct; 313(4):H690-H699. PubMed ID: 28754718
[TBL] [Abstract][Full Text] [Related]
18. Sustained Release of a Peptide-Based Matrix Metalloproteinase-2 Inhibitor to Attenuate Adverse Cardiac Remodeling and Improve Cardiac Function Following Myocardial Infarction.
Fan Z; Fu M; Xu Z; Zhang B; Li Z; Li H; Zhou X; Liu X; Duan Y; Lin PH; Duann P; Xie X; Ma J; Liu Z; Guan J
Biomacromolecules; 2017 Sep; 18(9):2820-2829. PubMed ID: 28731675
[TBL] [Abstract][Full Text] [Related]
19. Matrix metalloproteinase inhibition modifies left ventricular remodeling after myocardial infarction in pigs.
Yarbrough WM; Mukherjee R; Brinsa TA; Dowdy KB; Scott AA; Escobar GP; Joffs C; Lucas DG; Crawford FA; Spinale FG
J Thorac Cardiovasc Surg; 2003 Mar; 125(3):602-10. PubMed ID: 12658202
[TBL] [Abstract][Full Text] [Related]
20. Dimethyl fumarate preserves left ventricular infarct integrity following myocardial infarction via modulation of cardiac macrophage and fibroblast oxidative metabolism.
Mouton AJ; Flynn ER; Moak SP; Aitken NM; Omoto ACM; Li X; da Silva AA; Wang Z; do Carmo JM; Hall JE
J Mol Cell Cardiol; 2021 Sep; 158():38-48. PubMed ID: 34023353
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
